NCT03441204View on ClinicalTrials.gov

REgistry-based Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX)

PHASE4CompletedINTERVENTIONAL

Enrollment

241

Participants

Timeline

Start Date

May 16, 2018

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2023

Conditions

Chronic Respiratory Failure With Hypoxia

Interventions

DRUG

LTOT 24 h/day

LTOT prescribed for 24 h/day.

DRUG

LTOT 15h/day

: LTOT prescribed for 15 h/day. The patient is instructed to use LTOT during sleep and not to use LTOT for about 9 hours during daytime, totalling 15 h/day.

Trial Locations (2)

SE-37185

Blekinge hospital, Karlskrona

SE-70185

Örebro University Hospital, Örebro

All Listed Sponsors

collaborator

Lund University

OTHER

collaborator

Blekinge County Council Hospital

OTHER

lead

Skane University Hospital

OTHER

NCT03441204 - REgistry-based Treatment Duration and Mortality in Long-term OXygen Therapy (REDOX) | Biotech Hunter | Biotech Hunter